BreatheSuite to Sponsor and Exhibit at HLTH 2021

BreatheSuite to Sponsor and Exhibit at HLTH 2021

Company Recently Received FDA Clearance for Over-the-Counter Device to Turn Regular Metered-Dose Inhalers into Smart Inhalers

WHO: BreatheSuite, a connected respiratory health company, is sponsoring and exhibiting at this year’s HLTH Conference, the largest and most important conference for health innovation.

WHAT: HLTH 2021 is the preeminent event designed for the health industry, bringing together senior leaders to solve healthcare’s most pressing problems and realize the most promising opportunities to create health’s future.

For every 100 people who use an inhaler, 90 are using it incorrectly; 66 are not adherent to the medication as prescribed (skipping doses, etc.). c for both prescription and over-the-counter use, BreatheSuite’s device turns existing metered-dose inhalers (MDIs) into smart inhalers by automatically and objectively monitoring and providing feedback on inhaler adherence and technique. The BreatheSuite System – composed of a disposable, battery-powered, portable BreatheSuite MDI add-on device and a mobile application based on behavior change strategies – is designed to work with an MDI by attaching to the top of the canister of the patient’s inhaler. The device and mobile app work together to evaluate and “score” a person’s inhaler technique and usage patterns, storing results in the cloud so the person can track and use this information to improve how they use their inhaler. With consent, this information can also be remotely monitored by the person’s healthcare team to promote customizable care plans. By promoting more effective inhaler use and remote patient monitoring (RPM), BreatheSuite aims to improve quality of care and health outcomes while reducing the economic burden associated respiratory conditions such as asthma and COPD.

WHEN: HLTH will be held on October 17 -20, 2021 both in-person and virtually.  

WHERE: HLTH is a hybrid event, taking place in-person at The Boston Convention & Exhibition Center Broadmoor, 415 Summer Street, Boston, MA 02210, and virtually. BreatheSuite will be located in booth #1155-4.

About BreatheSuite

BreatheSuite is a Canadian connected health company founded in 2018 to help people with chronic respiratory conditions live longer, healthier lives. The BreatheSuite MDI device, which received 510(K) clearance from the U.S. Food and Drug Administration (FDA) for prescription and over-the-counter use, is compatible with 90% of MDIs on the market to track and train proper inhaler usage. Coupled with a mobile application built on behavior change strategies, it provides tips to improve inhaler adherence and technique, and enables remote patient monitoring. Also cleared for sale in Canada, BreatheSuite works with leading partners across North America to deliver better care to people with conditions such as asthma and COPD.

For more information visit or contact

Media Contact:
Rita Murphy
SVM Public Relations and Marketing Communications
(401) 490-9700


Download our Case Study

Click Here
Thank you! You can now downoad our Case Study!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Back to Newsroom
Cookie Notice
Please know that cookies are required to operate and enhance our products and services, as well as for advertising and analytical purposes. We value your privacy. If you are not comfortable with us collecting and using cookies, please review your settings before continuing.
Our Privacy Policy